Published July 30, 2021
| Version v1
Journal article
Open
The SARS-CoV-2 Programmed −1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 Å Using Chaperone-Assisted RNA Crystallography
- 1. University of Chicago
- 2. University of Maryland Baltimore County
Description
The programmed −1 ribosomal frameshifting element (PFSE) of SARS-CoV-2 is a well conserved structured RNA found in all coronaviruses' genomes. By adopting a pseudoknot structure in the presence of the ribosome, the PFSE promotes a ribosomal frameshifting event near the stop codon of the first open reading frame Orf1a during translation of the polyprotein pp1a. Frameshifting results in continuation of pp1a via a new open reading frame, Orf1b, that produces the longer pp1ab polyprotein. Polyproteins pp1a and pp1ab produce nonstructural proteins NSPs 1–10 and NSPs 1–16, respectively, which contribute vital functions during the viral life cycle and must be present in the proper stoichiometry. Both drugs and sequence alterations that affect the stability of the −1 programmed ribosomal frameshifting element disrupt the stoichiometry of the NSPs produced, which compromise viral replication. For this reason, the −1 programmed frameshifting element is considered a promising drug target. Using chaperone assisted RNA crystallography, we successfully crystallized and solved the three-dimensional structure of the PFSE. We observe a three-stem H-type pseudoknot structure with the three stems stacked in a vertical orientation stabilized by two triple base pairs at the stem 1/stem 2 and stem 1/stem 3 junctions. This structure provides a new conformation of PFSE distinct from the bent conformations inferred from midresolution cryo-EM models and provides a high-resolution framework for mechanistic investigations and structure-based drug design.
Files
roman-et-al-2021-the-sars-cov-2-programmed-1-ribosomal-frameshifting-element-crystal-structure-solved-to-2-09-å-using.pdf
Files
(4.9 MB)
| Name | Size | Download all |
|---|---|---|
|
Supporting information md5:e1e953c9e8e9ad59150abdf0fd6599f0 |
381.0 kB | Preview Download |
|
Article md5:d414952a2c74e84febba740b8ed538eb |
4.5 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1021/acschembio.1c00324
- Other
- oai:uchicago.tind.io:13462
Funding
- National Institutes of Health
- GM102489
- HHMI
- Gilliam Fellowship
- National Institutes of Health
- Chemical Biology Training Grant
- National Institutes of Health
- GM124165
- National Institutes of Health
- RR029205
- U.S. Department of Energy
- DE-AC02-06CH11357